Andres Briseno
Vermogen: 939 543 $ op 31-07-2026
Vermogen: 939 543 $ op 31-07-2026
Andres Ruiz Briseno is Chief Accounting Officer at IDEAYA Biosciences, Inc. since 2025.
Previously, Mr. Briseno was Associate Director-Financial Planning & Analysis at Pharmacyclics LLC from 2013 to 2016.
Mr. Briseno completed an undergraduate degree at San Jose State University in 2009.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-07-2026 | 26.466 ( 0,03% ) | 939 543 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01-08-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau